June 5 (Reuters) - CSL Ltd (CSL) :
- INJECTAFER APPROVED IN U.S. FOR TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE
News: CSL CSL Ltd Says Injectafer Approved In U.S.
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$273.73 |
Change
0.430(0.16%) |
Mkt cap ! $132.0B | |||
| Open | High | Low | Value | Volume |
| $274.75 | $275.12 | $272.56 | $30.17M | 110.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19 | $273.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $273.75 | 126 | 8 |
View Market Depth
| Last trade - 12.48pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$273.06 |
Change
0.430 ( 0.11 %) |
||||
| Open | High | Low | Volume | ||
| $274.80 | $275.12 | $272.60 | 12400 | ||
| Last updated 13.07pm 29/04/2024 ? | |||||
| CSL (ASX) Chart |